Posaconazole Tablet, Delayed Release
Product Images NDC 59651-596

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 59651-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg (60 Tablets Bottle))

Posaconazole Delayed-Release Tablets 100 mg label showing a beige, oblong tablet imprinted with '100'. The label states Rx only and a count of 60 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India, with instructions to store between 20° to 25°C. The label includes a caution that posaconazole tablets are not interchangeable with the oral suspension.*

FDA Label Image

Str (Posaconazole Str)

Chemical structure of Posaconazole, showing its molecular components and arrangement as depicted in the image associated with the delayed release tablet dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.